Tesamorelin alternatives.

10 compounds compared to Tesamorelin, ranked by published evidence tier and regulatory status, not by what's marketed hardest.

Why people look for an alternative

Tesamorelin is one of the few compounds in this class holding full FDA approval, so the alternatives search is almost always about the narrowness of that approval or its price. Egrifta is approved solely to reduce excess visceral abdominal fat in HIV-infected adults with lipodystrophy, which means everyone outside that population is looking at an off-label prescription. That is what drives people toward the wider secretagogue market, and the trade is worth stating plainly: every GHRH analog and ghrelin mimetic below has less evidence and less regulatory standing than tesamorelin, not more. You are trading a specific approval for availability, not upgrading the science.

What you're comparing against
Tesamorelin
A tier · 87/100FDA-approved

Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone (GHRH/GRF 1-44), stabilized by a trans-3-hexenoic acid group attached to its N-terminus.

Ranked by evidence · strongest first
  1. 01
    Sermorelin
    C tierResearch / preclinical

    Acts through the ghrh signalling pathway, like Tesamorelin. Research / preclinical.

  2. 02
    CJC-1295
    F tierResearch / preclinical

    Acts through the ghrh signalling pathway, like Tesamorelin. Research / preclinical.

  3. 03
    CJC-1295 DAC
    F tierResearch / preclinical

    Acts through the ghrh signalling pathway, like Tesamorelin. Research / preclinical.

  4. 04
    Mod-GRF (1-29)
    F tierResearch / preclinical
    CJC-1295 no-DAC

    Acts through the ghrh signalling pathway, like Tesamorelin. Research / preclinical.

  5. 05
    Human Growth Hormone
    S tierFDA-approved
    HGH · somatropin

    Same category: growth hormone. FDA-approved.

  6. 06
    ACE-031
    D tierIn human trials
    ramatercept · ActRIIB-Fc

    Same category: growth hormone. In human trials.

  7. 07
    GHRP-1
    D tierResearch / preclinical
    growth hormone-releasing peptide-1

    Same category: growth hormone. Research / preclinical.

  8. 08
    GHRP-2
    D tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

  9. 09
    GHRP-6
    D tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

  10. 10
    Hexarelin
    D tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

How this list is built

An “alternative” here means a compound that shares Tesamorelin's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.

Comparing options with your provider?

PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds